🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.980
+0.070 (2.41%)
Nov 18, 2026, 4:00 PM EST - Market closed

Galectin Therapeutics Market Cap

Galectin Therapeutics has a market cap or net worth of $300.61 million as of November 18, 2026. It is the 17,852nd most valuable company in the world and the 3,150th biggest in the United States. Its market cap has decreased by 22.28% in one year.

Market Cap
300.61M
Enterprise Value
327.76M
1-Year Change
-22.28%
Global Rank
Country Rank
#3,150 United States
Category

Chart

Chart

Since September 10, 2003, Galectin Therapeutics's market cap has increased from $106.80M to $300.61M, an increase of 181.47%. That is a compound annual growth rate of 4.56%.

History

DateMarket Cap% Change
Nov 18, 2026300.61M12.08%
Dec 31, 2025268.20M231.11%
Dec 31, 202481.00M-21.13%
Dec 29, 2023102.70M52.83%
Dec 30, 202267.20M-45.28%
Dec 31, 2021122.80M-3.99%
Dec 31, 2020127.90M-21.39%
Dec 31, 2019162.70M15.31%
Dec 31, 2018141.10M18.57%
Dec 29, 2017119.00M313.19%
Dec 30, 201628.80M-26.53%
Dec 31, 201539.20M-48.96%
Dec 31, 201476.80M-48.11%
Dec 31, 2013148.00M352.60%
Dec 31, 201232.70M-55.81%
Dec 30, 201174.00M32.14%
Dec 31, 201056.00M288.89%
Dec 31, 200914.40M234.88%
Dec 31, 20084.30M-84.81%
Dec 31, 200728.30M111.19%
Dec 29, 200613.40M-83.91%
Dec 30, 200583.30M21.96%
Dec 31, 200468.30M-23.94%
Dec 31, 200389.80M-15.92%
Sep 10, 2003106.80M-
View and export this data all the way back to 2003. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding